Type
Buy
Instrument
PFIZER
Entry Price
₹4,415
Price@Trade
₹4,415
Target Price
₹7,000
Stop Price
₹2,000
Valid Till
Aug 6, 2021 3:20 AM
Margin
₹22,075 approx for 5 Qty
Status
Active
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live PFIZER message board: Is PFIZER buy or sell? Should I buy PFIZER shares? Why are PFIZER shares falling? Should I invest in PFIZER stock?
forum
PFIZER Share Price Discussion
Pfizer Ltd.
NSE: PFIZER | BSE: 500680 | ISIN: INE182A01018 | Sector: Pharmaceuticals and health care
N
Reputation: 4,721 • Jun 15 12:46 PM
Pfizer Q4 results: Net profit declines 6% to Rs 103 crore
The company had posted a net profit of Rs 109.47 crore in the corresponding period of the previous fiscal.
The company had posted a net profit of Rs 109.47 crore in the corresponding period of the previous fiscal.
The Economic Times
Like
Reply
NSE:PFIZER price when posted: 4,035.1
Recent posts in PFIZER
N
Reputation: 4,721 • Aug 3 3:31 AM
Pricing Covid-19 vaccines too high could backfire on big pharmaceutical companies
A world without global intellectual property would be one of constant electronic warfare. State-backed hacking, such as China apparently tried with Moderna this week, would be a constant threat. Nor would companies enjoy a comfortable relationship with their own governments, who would see them less as engines of growth and more as storehouses of national wealth.
A world without global intellectual property would be one of constant electronic warfare. State-backed hacking, such as China apparently tried with Moderna this week, would be a constant threat. Nor would companies enjoy a comfortable relationship with their own governments, who would see them less as engines of growth and more as storehouses of national wealth.
The Economic Times
Like
Reply
N
Reputation: 4,721 • Jul 30 5:41 AM
'Vaccine nationalism': Is it one country against other in the race for a Covid-19 shot?
That's the fear of global health agencies planning a scheme to bulk-buy and equitably distribute vaccines around the world. They are watching with dismay as some wealthier countries have decided to go it alone, striking deals with drugmakers to secure millions of doses of promising candidates for their citizens.
That's the fear of global health agencies planning a scheme to bulk-buy and equitably distribute vaccines around the world. They are watching with dismay as some wealthier countries have decided to go it alone, striking deals with drugmakers to secure millions of doses of promising candidates for their citizens.
The Economic Times
Like
Reply
S
Reputation: 41,683 • Jul 28 4:24 AM
*Pfizer Ltd.* | *CMP* Rs. 4371 | *M Cap* Rs. 19996 Cr | *52 W H/L* 4999/2612
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 514.9 Cr (2.6% QoQ, -5.4% YoY) vs QoQ Rs. 502 Cr, YoY Rs. 544.4 Cr
EBIDTA came at Rs. 186.3 Cr (71.4% QoQ,...
Read more...
1
Reply
N
Reputation: 4,721 • Jul 28 3:28 AM
Pfizer Standalone June 2020 Net Sales at Rs 514.89 crore, down 5.42% Y-o-Y
Moneycontrol
Like
Reply